Prof. Zhiling Zhang 张志凌
Chief Physician, Professor
Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Kidney-sparing surgery for renal tumors (robotic, laparoscopic, open), comprehensive treatment of complex or large renal tumors, and surgical treatment of retroperitoneal tumors.
Dr. Zhang holds an MD and is a Chief Physician. From 2014 to 2015, Dr. Zhang studied at Cleveland Clinic under Professor Steven Campbell, focusing on kidney-sparing surgery and minimally invasive ablation. Dr. Zhang leads prospective clinical studies on renal function preservation, including neoadjuvant targeted immunotherapy and cold ischemia robotic partial nephrectomy.
Professional roles
- Member, Chinese Medical Association
- Member, Youth Study Group of Urology Branch, Chinese Medical Association
- Member, Renal Cancer Quality Control Committee, National Cancer Quality Control Center
- Member, Urological Tumor Professional Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Zhang Zhiling). Papers usually list the name as Zhiling Zhang or Zhang Z.
Selected publications
104 papers on PubMed matched by name and affiliation; 25 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cell Prolif, 2026 (senior author): Targeting a Novel AREG(+) Dendritic Cell Alleviates Renal Fibrosis Induced by Ischemia-Reperfusion Injury. PubMed 42833284
- Nat Commun, 2026 (senior author): Multimodal deep learning model for AI-based functional prognostic risk stratification in patients undergoing radical nephrectomy. PubMed 42209536
- Int Braz J Urol, 2026 (senior author): Minimally Invasive Partial versus Radical Nephrectomy for Non-metastatic pT3a Renal Cell Carcinoma: a Multicenter Matched Cohort Study. PubMed 41643050
- Ann Surg Oncol, 2026 (senior author): Correction: Selective Artery Clamping Superior to Main Artery Clamping in Preserving Ipsilateral Renal Function after Minimally Invasive Partial Nephrectomy under Prolonged Warm Ischemia. PubMed 41545615
- Ann Surg Oncol, 2026 (senior author): Selective Artery Clamping Superior to Main Artery Clamping in Preserving Ipsilateral Renal Function after Minimally Invasive Partial Nephrectomy under Prolonged Warm Ischemia. PubMed 41441934
- World J Urol, 2026 (senior author): Functional and volumetric changes following partial nephrectomy for large (≥ 7 cm) renal masses: a comparative study. PubMed 41733685
- Front Med (Lausanne), 2025 (senior author): Comparative study of eGFR in cancer and non-cancer individuals: a multicenter analysis. PubMed 41426566
- Urol Oncol, 2025 (senior author): Can parenchymal volume analysis replace nuclear renal scans for split renal function before and after partial nephrectomy with warm ischemia?. PubMed 39799091
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion